• Publications
  • Influence
In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.
PURPOSE To correlate in vitro characteristics of tumor-infiltrating lymphocytes (TIL) with clinical response to TIL immunotherapy in patients with metastatic melanoma. PATIENTS AND METHODSExpand
  • 151
  • 5
Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.
PURPOSE To search for tumor-specific in vitro reactivity by lymphocytes derived from patients with ovarian carcinoma. METHODS Tumor-infiltrating lymphocytes (TIL) were derived from primary orExpand
  • 52